On August 12, 2019, Surgent, a Spire Capital Partners portfolio company, announced the acquisition of Pharmaceutical Education Consultants, Inc. (“PharmCon”), as an expansion further into the continuing education and exam preparation markets. Surgent provides end-to-end professional education for accounting, finance, and tax professionals, guiding students through credentialing exams and working professionals through continuing education courses. PharmCon is the largest provider of continuing education for pharmacists, pharmacy technicians, and other healthcare professionals. Surgent seeks to enhance PharmCon’s webinar experience by leveraging Surgent’s innovative technology for a more engaging continuing education experience. While PharmCon’s current focus is on continuing education webinars, Surgent also sees an opportunity to move into the exam prep course space for pharmaceutical and other healthcare markets, using their proprietary adaptive learning technology, A.S.A.P. Technology.